Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV 4-valent vaccine for recurrent respiratory papillomatosis in children
2013-003049-41Phase 3Terminated
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Nov 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of qHPV vaccine in Laryngeal papilloma (RRP), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Number of relapses and surgeries after vaccination. Started Nov 2013; status: terminated.
02
Drugs
qHPV vaccine
03
Conditions
Laryngeal papilloma (RRP)
Beyond the preview
Go deeper on 2013-003049-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003049-41.